TITLE

DOES DIET WORK IN PATIENTS WITH NASH AND DYSLIPIDAEMIA? A FOLLOW UP STUDY OF WEIGHT, LIVER BIOCHEMISTRY, AND SERUM LIPIDS

AUTHOR(S)
Benedict, A.; Tang, S.; Joshi, D.; Panteli, J.; Brothers, S.; Crook, M.; O'Donohue, J.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA102
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction and Aims: Non-alcoholic steatohepatitis (NASH) has been associated with the insulin-resistant states. We aimed to investigate the prevalence of insulin resistant features in patients with both NASH and dyslipidaemia, to characterise changes over time in weight, liver biochemistry, serum lipids, and triglycerides, and to determine the effect of dietary advice. Methods: 39 patients with both NASH and dyslipidaemia were identified from the Lipid and Gastroenterology Databases (19962001). Alcoholic, viral, autoimmune, or other metabolic diagnoses excluded. Results: 21 patients were female. Mean age at fist visit was 52.3 years, weight 80.7 kg, BM129.03 kg/m²; 48% were overweight and a further 40% obese. 67.7% were hypertensive and 30.8% were diabetic, of whom 50% were on diet alone. 20.5% were taking statins, 12.8% fibrates, and 7.7% omega-3 oils. Mean follow up was 583 days (median 400 days). Mean weight decreased from 80.7 to 80.25 kg (p = NS), total cholesterol from 6.40 to 6.04 mmol/I (p = 0.053), triglycerides from 3.59 to 3.40 mmol/I (p = NS) and the ratio of total cholesterol to HDL decreased from 5.9 to 4.5 (p < 0.02) with a corresponding increase in mean HDL from 1.08 to 1.35 mmol/I (p < 0.018). Mean ALT decreased from 57.1 to 55.7 iu/I (p = NS), with weight change significantly associated with ALT change (R² = 0.056, p < 0.04). Patients referred for for weight and lipid lowering diets were significantly heavier at baseline (83.3 kg, n = 19) than those not referred (77.1 kg, n = 19, p < 0.01); neither group lost weight, but total cholesterol (by 0.31 mmol/I) and serum triglycerides (by 0.38 mmol/I) fell in the advice group only (excluding patients on lipid lowering agents) (p < 0.03). Conclusion: These patients with both NASH and dyslipidaemia also had a strikingly high prevalence of hypertension, obesity, and diabetes mellitus. Dietary advice produced no overall weight loss in the group but appeared to improve lipid profile. ALT...
ACCESSION #
9747978

 

Related Articles

  • Insulin sensitivity and blood lipid profile in women recreationally practicing horseback riding. Kaczmarek, Agnieszka; Nowak, Alicja; Pilaczyńska-Szcześniak, Łucja // Studies in Physical Culture & Tourism;2012, Vol. 19 Issue 3, p135 

    Introduction. The increased number of metabolic disorders associated with modern sedentary life indicates the need for a health-promoting activity. Horseback riding has become popular among some people, especially women, who seek attractive forms of physical exercises. Aim of Study. The purpose...

  • Relationship between cardiovascular risk factors and blood adiponectin in diabetic males. Izadi, M.; Zarifian, A.; Eghdami, A.; Khorshidi, D.; Doeli, H. // Iranian South Medical Journal;2012, Vol. 15 Issue 2, p101 

    Background: Obesity-related disorders characterized by insulin resistance such as metabolic syndrome, hypertension, coronary artery disease and type 2 diabetes are associated with decreased adiponectin levels. The purpose of the present study was to determine association of lipid profile and...

  • Assessment of the Ability of the Triglyceride to High Density Lipoprotein Cholesterol Ratio to Discriminate Insulin Resistance among Caribbean-born Black Persons with and without Hispanic Ethnicity. Tull, E. S. // West Indian Medical Journal;Feb2013, Vol. 62 Issue 2, p109 

    Objective: The objective of this research was to determine if the triglyceride (TG) to high density lipoprotein (HDL) cholesterol (TG/HDL) ratio has similar utility for discriminating insulin resistance in Caribbean-born black persons with and without Hispanic ethnicity. Methods: Serum lipids,...

  • Metabolic Complications Associated with HIV Infection and Antiretroviral Therapy. Powderly, William // AIDS Patient Care & STDs;Aug2004, Vol. 18 Issue 8, p431 

    The article presents an interview with William Powderly, a professor of medicine at Washington University School of Medicine in St. Louis, Missouri. Powderly says that in general, HIV-related or antiretroviral therapy-related metabolic complication refers to a constellation of different...

  • Lipids and Lipoproteins in Patients With Type 2 Diabetes. Krauss, Ronald M. // Diabetes Care;Jun2004, Vol. 27 Issue 6, p1496 

    Insulin resistance and type 2 diabetes are associated with a clustering of interrelated plasma lipid and lipoprotein abnormalities, which include reduced HDL cholesterol, a predominance of small dense LDL particles, and elevated triglyceride levels. Each of these dyslipidemic features is...

  • Insulin Action and Secretion, Plasma Lipids and Blood Pressure (BP) in Japanese Subjects with Impaired Fasting Glucose (IFG) and/or Impaired Glucose Tolerance (IGT). Miyazaki, Yoshinori; Saitoh, Shigeyuki; Akasaka, Hiroshi; Ohnishi, Hirofumi; Defronzo, Ralph A.; Shimamoto, Kazuaki // Diabetes;Jun2007 Supplement 1, Vol. 56, pA241 

    The aim of this cross-sectional study was to examine insulin action and secretion, plasma lipids and BP in subjects with IFG and/or IGT in 1399 Japanese subjects (age=58.8±0.3 yrs; M/F=637/762) who were not taking any medications known to affect glucose tolerance, BP or plasma lipids. All...

  • Hepatitis C and hepatic steatosis. Patel, J. H.; Cobbold, J. F. L.; Thomas, H. C.; Taylor-Robinson, S. D. // QJM: An International Journal of Medicine;May2010, Vol. 103 Issue 5, p293 

    Hepatic steatosis is commonly seen in patients with chronic hepatitis C infection, and the two together have a greater association than by chance alone. Hepatitis C virus is closely associated with lipid metabolism throughout its lifecycle. Hepatic steatosis is more common in genotype 3...

  • Metformin for Prevention of Weight Gain and Insulin Resistance With Olanzapine: A Double-Blind Placebo-Controlled Trial. Baptista, Trino; Martínez, Jessan; Lacruz, Anny; Rangel, Nairy; Beaulie, Serge; Serrano, Ana; Arapé, Yinet; Martinez, Maritza; de Mendoza, Soaira; Teneud, Luis; Hernández, Luis // Canadian Journal of Psychiatry;Mar2006, Vol. 51 Issue 3, p192 

    Objective: To assess whether metformin prevents body weight gain (BWG) and metabolic dysfunction in patients with schizophrenia who are treated with olanzapine. Method: Forty patients taking olanzapine (10 mg daily) were randomly allocated to a metformin (n = 20; 850 to 1700 mg daily) or placebo...

  • Insulin, lipid profiles and measures of fatness in Taiwanese women in relation to duration of residence in Australia. Wan-Ping Lee; Lingard, Jennifer; Bermingham, Margaret // Asia Pacific Journal of Clinical Nutrition;2007, Vol. 16 Issue 2, p254 

    This study investigated the relationships between measures of fatness and blood insulin and lipids in Taiwanese females living in Taiwan (n=97) or Australia (n=100), and examined the effect of length of residence in Australia on these relationships. Fasting glucose and lipids were determined by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics